Intracameral platelet-rich plasma shows efficacy for severe, chronic hypotony

Intracameral platelet-rich plasma injected into the anterior chamber can treat cases of chronic hypotony that are nonresponsive to other treatment options, according to Jorge L. Alió, MD, PhD.
“The hypothesis is that the combination of the fibrin’s sealant properties with growth factors seal the overfiltering and leaky areas and revitalize the tissue,” Alió said.
Platelet-rich plasma is a blood-derived product containing growth factors and cell adhesion molecules. Several reports have demonstrated its efficacy in various fields of medicine, including

Full Story →